NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
28.72
-1.73 (-5.68%)
At close: Apr 28, 2026, 4:00 PM EDT
28.60
-0.12 (-0.42%)
After-hours: Apr 28, 2026, 6:32 PM EDT
NAMS Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for NAMS stock have an average target of 46.75, with a low estimate of 37 and a high estimate of 52. The average target predicts an increase of 62.78% from the current stock price of 28.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 19, 2026.
Analyst Ratings
The average analyst rating for NAMS stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $41 → $45 | Strong Buy | Maintains | $41 → $45 | +56.69% | Feb 19, 2026 |
| Needham | Needham | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +67.13% | Feb 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +63.65% | Jan 21, 2026 |
| Stifel | Stifel | Strong Buy Maintains $44 → $50 | Strong Buy | Maintains | $44 → $50 | +74.09% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +28.83% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
26.55M
from 22.50M
Increased by 17.96%
Revenue Next Year
170.06M
from 26.55M
Increased by 540.65%
EPS This Year
-1.98
from -1.72
EPS Next Year
-1.45
from -1.98
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 43.2M | 631.5M | ||||||
| Avg | 26.5M | 170.1M | ||||||
| Low | n/a | 23.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 91.8% | 2,278.9% | ||||||
| Avg | 18.0% | 540.6% | ||||||
| Low | - | -11.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.53 | 2.48 | ||||||
| Avg | -1.98 | -1.45 | ||||||
| Low | -2.40 | -3.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.